Skip to main content

Table 1 Demographic characteristics of the study participants

From: Evaluation of tau deposition using 18F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study

 

Baseline dataset

Subset with longitudinal cognitive information

p1

Subset with longitudinal PET scans

p2

n

74

36

 

15

 

Age (years)

75.78 ± 6.61 (54, 85)

75.69±7.13 [55, 85]

N.S

75.33 ± 8.92 (57, 85)

N.S

Sex

36 (48.6%) M

17 (47.2%) (M)

N.S

8 (53.3%) M

N.S

38 (51.4%) F

19 (52.8%) (F)

 

7 (46.7%) F

 

Clinical diagnosis

72 (MCI due to AD)

34 (MCI due to AD)

N.S

14 (MCI due to AD)

N.S

2 (mild AD)

2 (mild AD)

 

1 (Mild AD)

 

MMSE

26.51 ± 2.5 (20, 30)

26.31±2.56 [21, 30]

N.S

26.93 ± 2.41 (21, 30)

N.S

CDR-SB

2.35 ± 1.04 (0.5, 5)

2.51±1.1 [0.5, 5]

N.S

2.47 ± 0.79 (1, 4)

N.S

CL

71.64±40.07 (−13.39, 181.87)

71.81±36.14 [7.2, 154.75]

N.S

62.16±41.46 (7.2, 154.75)

N.S

SUVR (PI-2620)

1.28±0.35 [0.89, 2.43]

1.31±0.39 [0.89, 2.43]

N.S

1.1±0.17 [0.89, 1.65]

p=0.01

  1. MCI mild cognitive impairment, AD Alzheimer’s disease, MMSE Mini-Mental State Examination, CDR-SB Clinical dementia rating – Sum of boxes, CL (18F-florbetaben) centiloid at baseline, SUVR(18F-PI-2620) Standardized uptake value for 18F-PI-2620 scans at baseline in the inferior temporal cortex, p1p-values comparing the demographic characteristics between the subset of subjects with longitudinal cognitive information and the remaining subjects from the baseline dataset (Wilcoxon rank sum (continuous variables) test and chi-squared test (categorical variables)), p2p-values comparing the demographic characteristics between the subset of subjects with longitudinal 18F-PI-2620 scans and the remaining subjects from the baseline dataset (Wilcoxon rank sum test (continuous variables) and chi-squared test (categorical variables)), N.S non-significant differences (p>0.05)